Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05456321 · ClinicalTrials.gov registry record · NA
CIFASD 5 tDCS and Cognitive Training
A NA study of Fetal Alcohol Spectrum Disorders, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT05456321: Recruiting NA study of Fetal Alcohol Spectrum Disorders, sponsored by University of Minnesota.
NCT05456321 is a NA study of Fetal Alcohol Spectrum Disorders that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 70 participants, below the 99-participant average among 10 other Fetal Alcohol Spectrum Disorders trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05456321, a NA study of Fetal Alcohol Spectrum Disorders, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 8 - 17 years) with prenatal alcohol exposure (PAE).
Primary Outcome
Change in Continuous Performance Test performance
Conditions Studied
Interventions
- DEVICE Sham tDCS
- DEVICE Active tDCS
- BEHAVIORAL Cognitive Training
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2022-11-10 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
What NCT05456321 shows while recruiting
NCT05456321 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 99-participant average among 10 other Fetal Alcohol Spectrum Disorders trials with a reported enrollment target (29% lower).
The record links to 1 condition, with Fetal Alcohol Spectrum Disorders appearing as the primary indexed condition, and to 3 interventions - of which Sham tDCS is the first listed.
NCT05456321 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05456321 about?
NCT05456321 is a clinical study titled "CIFASD 5 tDCS and Cognitive Training". This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 8 - 17 years) with prenatal alcohol exposure (PAE).
What is the current status of trial NCT05456321?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2022-11-10. Estimated completion is 2027-05-31.
What conditions does trial NCT05456321 study?
This clinical trial studies the following conditions: Fetal Alcohol Spectrum Disorders.
What interventions are being tested in trial NCT05456321?
The interventions under investigation include: Sham tDCS (DEVICE), Active tDCS (DEVICE), Cognitive Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05456321?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05456321 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fetal Alcohol Spectrum Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05456321's enrollment target sits among peer trials
70 5th of 10 higher than 6 of 10 other Fetal Alcohol Spectrum Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fetal Alcohol Spectrum Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Oklahoma Parent-Child Assistance Program
RECRUITING · NA
-
Families Moving Forward (FMF) Connect Pro for Mental Health Providers
RECRUITING · NA
-
The Synchrony Study: Examining Music Training for Children With FASD
RECRUITING · NA
-
Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure
RECRUITING · NA
-
My Health Coach App RCT
RECRUITING · NA
-
Study of the Families Moving Forward Website Behavioral Intervention for Teachers of Students With Fetal Alcohol Spectrum Disorder
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI